JSJinjie Shi

Jinjie Shi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jinjie Shi has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Guangcheng Wei

    Sports Medicine Department, Wangjing Hospital, China Academy of China Medical Sciences, Chaoyang District, Beijing, China

    1 shared publication
  • Jiming Yu

    The Second Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou, People’s Republic of China

    1 shared publication
  • Ke Zhu

    Rheumatology Department, Wangjing Hospital of China Academy of Chinese Medical Sciences, Beijing, People’s Republic of China

    1 shared publication
  • Shen Wang

    Orthopedics Department, Nanjing Integrated Traditional Chinese and Western Medicine Hospital, Nanjing, People’s Republic of China

    1 shared publication
  • Wei Cao

    Department of Rheumatology, Wang Jing Hospital of China Academy of Chinese Medical Sciences, Beijing 100102, China

    1 shared publication
  • Xieyu Zhang

    Rheumatology Department, Wangjing Hospital of China Academy of Chinese Medical Sciences, Beijing, People’s Republic of China

    1 shared publication

Latest Publications

  • Open Access

    New Posttranslational Modification Lactylation Brings New Inspiration for the Treatment of Rheumatoid Arthritis

    by Yue Yang, Jinjie Shi, Jiming Yu, Xin Zhao, Ke Zhu, Shen Wang, Xinwen Zhang, Xieyu Zhang, Guangcheng Wei, Wei Cao

    Lactic acid (LA) is an essential glycolytic metabolite and energy source in the body, which is present in high levels in the synovial fluid of patients with rheumatoid arthritis (RA) and is a reliable indicator for identifying inflammatory arthritis. LA not only acts as an inflammatory amplifier in RA, recent studies have found that novel posttranslational modification (PTM) lactylation mediated by LA may also play a key role in RA. Single-cell sequencing showed that the RA lactylation score of patients with RA was significantly increased, and core lactylation-promoting genes, including NDUFB3, NGLY1, and other genes, were found to be potential biomarkers of RA. More studies have shown that lactylation can regulate genes in various cells, such as fibroblast-like synoviocytes (FLSs) and macrophages, thus playing a special role in the development and occurrence of autoimmune diseases, neurological diseases, and cancer diseases. In this paper, we review the research on lactylation in RA-related cells and mechanisms and bring new insights into the pathogenesis, diagnosis, and treatment of RA.